{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:08:42Z","timestamp":1789038522859,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021- 125188OB-C32"],"award-info":[{"award-number":["PID2021- 125188OB-C32"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["TED2021- 129932B-C21"],"award-info":[{"award-number":["TED2021- 129932B-C21"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016028","name":"Ag\u00e8ncia Valenciana de la Innovaci\u00f3","doi-asserted-by":"publisher","award":["INNEST\/2022\/103"],"award-info":[{"award-number":["INNEST\/2022\/103"]}],"id":[{"id":"10.13039\/501100016028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["Ayuda de recualificaci\u00f3n profesorado universitario"],"award-info":[{"award-number":["Ayuda de recualificaci\u00f3n profesorado universitario"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"DOI":"10.1007\/s12325-026-03739-5","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:18:00Z","timestamp":1789035480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design of a New Predictive Equation for the Induction Dose of Tacrolimus in Immediate Renal Transplantation"],"prefix":"10.1007","author":[{"given":"Olga","family":"Guill\u00e9n-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8113-0795","authenticated-orcid":false,"given":"Enrique","family":"Barraj\u00f3n-Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Mart\u00ednez-Caballero","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Soriano-Irigaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Borr\u00e1s-Rocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Cruzado-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Sabater-Belmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Murcia-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"3739_CR1","unstructured":"Lorenzo V, Luis D. Enfermedad renal cr\u00f3nica. Nefrol al d\u00eda [Internet]. 2009;16(4):5\u201318. https:\/\/www.nefrologiaaldia.org\/136"},{"key":"3739_CR2","unstructured":"Boquet EM. Atenci\u00f3n farmac\u00e9utica al paciente trasplantado de \u00f3rgano s\u00f3lido. Soc Valencia Farm Hosp. 2020;13."},{"issue":"20","key":"3739_CR3","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.2217\/nnm-2019-0106","volume":"14","author":"JR Covvey","year":"2019","unstructured":"Covvey JR, Mancl EE. Pharmaceutical care in transplantation: current challenges and future opportunities. Nanomedicine. 2019;14(20):2651\u20138.","journal-title":"Nanomedicine"},{"key":"3739_CR4","doi-asserted-by":"publisher","unstructured":"Staatz C, Taylor P, Tett S. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrol Dial Transplant. 2001;16(9):1905\u20139. https:\/\/doi.org\/10.1093\/ndt\/16.9.1905","DOI":"10.1093\/ndt\/16.9.1905"},{"issue":"3","key":"3739_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, Van Gelder T, \u00c5sberg A, Haufroid V, Hesselink DA, Langman L, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit. 2019;41(3):261\u2013307.","journal-title":"Ther Drug Monit"},{"issue":"SUPPL. 2","key":"3739_CR6","first-page":"21","volume":"13","author":"F Oppenheimer Salinas","year":"2020","unstructured":"Oppenheimer Salinas F, Pascual Santos J, Pallard\u00f3 ML. Inmunosupresi\u00f3n en el trasplante renal. Nefrologia. 2020;13(SUPPL. 2):21\u20134.","journal-title":"Nefrologia"},{"key":"3739_CR7","unstructured":"Grupo Espa\u00f1ol de Farmacocin\u00e9tica y Farmacogen\u00f3mica de la SEFH. Manual de rotaci\u00f3n del residente por la unidad de farmacocin\u00e9tica cl\u00ednica. 1a Edici\u00f3n. 2011."},{"key":"3739_CR8","doi-asserted-by":"crossref","unstructured":"Wong SHY. Therapeutic drug monitoring for immunosuppressants. Clin Chim Acta [Internet]. 2001;313(1):241\u201353. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0009898101006787","DOI":"10.1016\/S0009-8981(01)00678-7"},{"key":"3739_CR9","doi-asserted-by":"crossref","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Changes in tacrolimus distribution in blood and plasma protein binding following liver transplantation. Ther Drug Monit [Internet]. 2004;26(5). https:\/\/journals.lww.com\/drug-monitoring\/Fulltext\/2004\/10000\/Changes_in_Tacrolimus_Distribution_in_Blood_and.8.aspx","DOI":"10.1097\/00007691-200410000-00008"},{"issue":"3","key":"3739_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/11317350-000000000-00000","volume":"49","author":"CE Staatz","year":"2010","unstructured":"Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet. 2010;49(3):141\u201375.","journal-title":"Clin Pharmacokinet"},{"key":"3739_CR11","doi-asserted-by":"publisher","unstructured":"Sikma MA, Hunault CC, Huitema ADR, De Lange DW, Van Maarseveen EM. Clinical pharmacokinetics and impact of hematocrit on monitoring and dosing of tacrolimus early after heart and lung transplantation. Clin Pharmacokinet [Internet]. 2020;59(4):403\u20138. https:\/\/doi.org\/10.1007\/s40262-019-00846-1","DOI":"10.1007\/s40262-019-00846-1"},{"key":"3739_CR12","doi-asserted-by":"crossref","unstructured":"Masuda S, Goto M, Okuda M, Ogura Y, Oike F, Kiuchi T, et\u00a0al. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients. Transplant Proc [Internet]. 2005;37(4):1728\u20139. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0041134505001983","DOI":"10.1016\/j.transproceed.2005.02.081"},{"key":"3739_CR13","doi-asserted-by":"crossref","unstructured":"Scheibner A, Remmel R, Schladt D, Oetting WS, Guan W, Wu B, et\u00a0al. Tacrolimus elimination in four patients with a CYP3A5*3\/*3 CYP3A4*22\/*22 genotype combination. 2019;1\u201312. www.ClinicalTrials.gov","DOI":"10.1002\/phar.2131"},{"key":"3739_CR14","doi-asserted-by":"crossref","unstructured":"Campagne O, Mager DE, Tornatore KM. Population pharmacokinetics of tacrolimus in transplant recipients: what did we learn about sources of interindividual variabilities? J Clin Pharmacol [Internet]. 2019;59(3):309\u201325. https:\/\/pubmed.ncbi.nlm.nih.gov\/30371942\/","DOI":"10.1002\/jcph.1325"},{"key":"3739_CR15","unstructured":"Vidal-alabr\u00f3 A, Colom H, Fontova P, Cerezo G, Melilli E, Torras J, et\u00a0al. Herramientas para un ajuste de dosis de tacrolimus m\u00e1s personalizado en el seguimiento de los pacientes con trasplante renal. Fenotipo metabolizador seg\u00fan polimorfismos gen\u00e9ticos del CYP3A vs. el cociente concentraci\u00f3n-dosis. Rev la Soc Espa\u00f1ola Nefrol. 2022;NEFRO-1122:1\u201313."},{"key":"3739_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3129389","author":"F Cheng","year":"2022","unstructured":"Cheng F, Li Q, Cui Z, Wang Z, Zeng F, Zhang Y. Tacrolimus concentration is effectively predicted using combined clinical and genetic factors in the perioperative period of kidney transplantation and associated with acute rejection. J Immunol Res. 2022. https:\/\/doi.org\/10.1155\/2022\/3129389.","journal-title":"J Immunol Res"},{"key":"3739_CR17","unstructured":"Herrero-Cervera MJ, Marqu\u00e9s-Mi\u00f1ana MR R-DN. Farmacogen\u00e9tica en el trasplante de \u00f3rganos. SEFH. 2010;MODULO 4."},{"key":"3739_CR18","unstructured":"Fern\u00e1ndez AM, Morales MA, \u00c1ngel M, Cepeda M, Manuel F, Roncero G, et\u00a0al. Monitorizaci\u00f3n farmacol\u00f3gica de inmunosupresores. Nefrologia. 2016;51\u201362."},{"key":"3739_CR19","doi-asserted-by":"crossref","unstructured":"KDIGO. KDIGO Clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(3):S1\u2013155 (Special Issue).","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"3739_CR20","unstructured":"Ruiz San Mill\u00e1n JC. Algoritmos en nefrolog\u00eda. Soc Espa\u00f1ola Nefrol. 2012;M\u00f3dulo 8."},{"key":"3739_CR21","unstructured":"P\u00e9rez Tamaj\u00f3n L. Complicaciones m\u00e9dicas precoces tras el trasplante renal. Nefrol al d\u00eda [Internet]. 2020;1\u201329. https:\/\/www.nefrologiaaldia.org\/140"},{"issue":"10","key":"3739_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","volume":"43","author":"CE Staatz","year":"2004","unstructured":"Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43(10):623\u201353.","journal-title":"Clin Pharmacokinet"},{"key":"3739_CR23","doi-asserted-by":"crossref","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, V\u00edtko \u0160, Nashan B, G\u00fcrkan A, et\u00a0al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med [Internet]. 2007;357(25):2562\u201375. https:\/\/pubmed.ncbi.nlm.nih.gov\/18094377\/","DOI":"10.1056\/NEJMoa067411"},{"key":"3739_CR24","doi-asserted-by":"publisher","unstructured":"Tang N, Maeda S, Okuda M. Population pharmacokinetic\/pharmacodynamic model of the impact of cumulative tacrolimus exposure on kidney function after liver transplant. Ther Drug Monit. 2025. https:\/\/doi.org\/10.1097\/FTD.0000000000001418. Online ahead of print. PMID: 41369519.","DOI":"10.1097\/FTD.0000000000001418"},{"key":"3739_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.717148","author":"A Piletta-Zanin","year":"2021","unstructured":"Piletta-Zanin A, De Mul A, Rock N, Lescuyer P, Samer CF, Rodieux F. Case report: low hematocrit leading to tacrolimus toxicity. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.717148.","journal-title":"Front Pharmacol"},{"key":"3739_CR26","doi-asserted-by":"publisher","unstructured":"Francke MI, Sassen SDT, Lloberas N, Colom H, Elens L, Moudio S, et\u00a0al. A population pharmacokinetic model and dosing algorithm to guide the tacrolimus starting and follow-up dose in living and deceased donor kidney transplant recipients. Clin Pharmacokinet [Internet]. 2025;64(9):1379\u201394. https:\/\/doi.org\/10.1007\/s40262-025-01533-0","DOI":"10.1007\/s40262-025-01533-0"},{"issue":"6","key":"3739_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/17410541.2025.2606641","volume":"22","author":"A Abderahmene","year":"2025","unstructured":"Abderahmene A, Francke MI, Ammar M, Andrews LM, Hesselink DA, Amor D, et al. A population pharmacokinetic model for early follow-up dosing of tacrolimus in Tunisian kidney transplant recipients. Per Med. 2025;22(6):455\u201365. https:\/\/doi.org\/10.1080\/17410541.2025.2606641.","journal-title":"Per Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03739-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03739-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03739-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:18:10Z","timestamp":1789035490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03739-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":27,"alternative-id":["3739"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03739-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Olga Guill\u00e9n\u2013Mart\u00ednez, Enrique Barraj\u00f3n-Catal\u00e1n, Daniel Mart\u00ednez-Caballero Mart\u00ednez, Leticia Soriano-Irigaray, Fernando Borr\u00e1s-Rocher, Leonidas Cruzado-Vega, Alejandra Sabater-Belmar and Ana Cristina Murcia-L\u00f3pez have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with Good Clinical Practice guidelines and international ethical principles applicable to medical research involving human participants (Declaration of Helsinki). The study was approved by the Ethics Committee for Research at the HGUE, with registration code PI 43\/2022 and the title \u201cIndividualized Tacrolimus Therapy through Pharmacokinetic Monitoring in Kidney Transplanted Patients.\u201d Additionally, an exemption from informed consent was requested from the committee and was granted.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}